THERADIAG , a company specializing in theranostic and in vitro diagnostic , today reports its half-year results for 2013 as approved by the Board of Directors on October 1, 2013.
http://www.biospace.com/news_story.aspx?StoryID=310512&full=1
http://www.biospace.com/news_story.aspx?StoryID=310512&full=1
No comments:
Post a Comment